Menu
Your Cart

Baritor 2 mg Tab

Baritor 2 mg Tab
Baritor 2 mg Tab
Tk25.00
0 Pcs sold
5930 Interested
This product has a minimum quantity of 10
Generic NameBaricitinib
Strength2 mg
Dosage FormTablet
ManufacturerSquare Pharmaceuticals PLC
Therapeutic ClassJanus Kinase (JAK) Inhibitor
Pack SizeEach box contains 28's tablets

Overview

Baritor Tablet contains Baricitinib, manufactured by Square Pharmaceuticals PLC. It is a Janus kinase (JAK1/JAK2) inhibitor used in the treatment of moderate to severe active rheumatoid arthritis and certain forms of alopecia areata, in patients with an inadequate response to other therapies.

Dosage and Administration

Usual adult dose: 2-4 mg once daily, with or without food, as advised by the physician based on disease severity and renal function. Dose adjustment may be required in renal impairment.

Interaction

Concomitant use with strong organic anion transporter 3 (OAT3) inhibitors such as probenecid may increase baricitinib exposure. Live vaccines should be avoided during treatment.

Contraindications

Contraindicated in patients with known hypersensitivity to baricitinib, active serious infections, and severe hepatic impairment.

Side Effects

Upper respiratory tract infections, nausea, headache, and elevated lipid levels. Increased risk of infections, including herpes zoster, has been reported.

Pregnancy and Lactation

Not recommended during pregnancy due to potential risk to the fetus; not recommended during breastfeeding as safety data are limited.

Precautions and Warnings

Increased risk of serious infections, malignancy, major cardiovascular events, and thrombosis has been associated with JAK inhibitors. Screen for tuberculosis and viral hepatitis before initiating therapy. Monitor lipid profile and blood counts periodically.

Storage Conditions

Store below 30°C, in a dry place, protected from light and moisture. Keep out of the reach of children.

Frequently Asked Questions

What conditions does Baritor treat?
It is used for moderate to severe active rheumatoid arthritis and certain types of alopecia areata when other treatments have not worked well enough.

What are the serious risks to be aware of?
JAK inhibitors like Baricitinib carry an increased risk of serious infections, blood clots, and certain cancers; regular monitoring by a physician is essential during treatment.

This content is for informational purposes only and does not substitute professional medical advice. Please consult a registered physician before taking any medication.

Write a review

Note: HTML is not translated!
Bad Good